H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
RSS |
|
Russell Silver syndrome
|
|
|
0.578 |
0.692 |
MIR660 |
|
microRNA 660
|
|
|
0.666 |
0.615 |
MIB1 |
Q86YT6
|
mindbomb E3 ubiquitin protein ligase 1
|
Enzyme
|
3.4E-88 |
0.438 |
0.769 |
DMBT1 |
Q9UGM3
|
deleted in malignant brain tumors 1
|
Enzyme
|
4.5E-63 |
0.533 |
0.654 |
ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
GIPR |
P48546
|
gastric inhibitory polypeptide receptor
|
G-protein coupled receptor
|
2.0E-29 |
0.670 |
0.538 |
MKI67 |
P46013
|
marker of proliferation Ki-67
|
|
1.3E-28 |
0.431 |
0.808 |
CHEK2 |
O96017
|
checkpoint kinase 2
|
Kinase
|
1.2E-24 |
0.460 |
0.808 |
NAT10 |
Q9H0A0
|
N-acetyltransferase 10
|
|
4.1E-22 |
0.536 |
0.769 |
ZACN |
Q401N2
|
zinc activated ion channel
|
|
4.3E-22 |
0.659 |
0.538 |
CYP11B2 |
P19099
|
cytochrome P450 family 11 subfamily B member 2
|
|
7.1E-19 |
0.553 |
0.615 |
ABCB6 |
Q9NP58
|
ATP binding cassette subfamily B member 6 (Langereis blood group)
|
Transporter
|
8.6E-19 |
0.431 |
0.885 |
MTRR |
Q9UBK8
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
2.2E-14 |
0.502 |
0.808 |
SLC5A2 |
P31639
|
solute carrier family 5 member 2
|
Transporter
|
4.9E-14 |
0.499 |
0.769 |
ALPP |
P05187
|
alkaline phosphatase, placental
|
Enzyme
|
1.8E-13 |
0.487 |
0.808 |
MTR |
Q99707
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
2.4E-12 |
0.482 |
0.808 |
AMH |
P03971
|
anti-Mullerian hormone
|
|
3.4E-12 |
0.476 |
0.846 |
OGG1 |
O15527
|
8-oxoguanine DNA glycosylase
|
|
3.9E-12 |
0.453 |
0.808 |
GHRL |
Q9UBU3
|
ghrelin and obestatin prepropeptide
|
|
1.4E-11 |
0.517 |
0.769 |
CA1 |
P00915
|
carbonic anhydrase 1
|
|
4.7E-11 |
0.623 |
0.769 |
CTSB |
P07858
|
cathepsin B
|
Enzyme
|
5.9E-11 |
0.457 |
0.846 |